Mineralys Sets Investor Update as Lorundrostat Advances
RADNOR, PA — Mineralys Therapeutics Inc. (Nasdaq: MLYS) will present to investors Sept. 9 at the Wells Fargo 21st Annual Healthcare Conference in Boston as the clinical-stage biotechnology company advances …
Mineralys Sets Investor Update as Lorundrostat Advances Read More